A. C. Nieuwenhuijzen Kruseman

Effects of a new oral hypoglycaemic agent, repaglinide, on metabolic control in sulphonylurea-treated patients with NIDDM

B. Wolffenbuttel, P. Menheere, J. Sels, 2004, European Journal of Clinical Pharmacology.